Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 August 1997:
Vol. 277. no. 5327, pp. 759 - 760
DOI: 10.1126/science.277.5327.759
Prev | Table of Contents | Next

News & Comment

BIOTECHNOLOGY:
NIH Nixes Appeal to Bypass Patent Law

Eliot Marshall

National Institutes of Health (NIH) director Harold Varmus sided with Johns Hopkins University last week in a high-profile patent dispute with a feisty biotech company, CellPro Inc. of Bothell, Washington. He turned down an appeal by CellPro for NIH to take control of a Hopkins patent on a widely touted cell-sorting technique. Just over a week earlier, Judge Roderick McKelvie of the federal court in Wilmington, Delaware, ordered CellPro to pay Hopkins and its commercial partners triple damages, amounting to $6,961,479, for infringing the university's patents.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)